Search results for “EP4 Receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,107 patents, we discovered top 67 key players by total patent application. Allergan, Inc., Glaxo Group Ltd., Merck Frosst Canada & Co. are dominant in this area. They take 25.29% of the total patent filing.
Allergan, Inc.
California, United States
Patent: 101
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 98
Merck Frosst Canada & Co.
Canada
Patent: 81
Pfizer Products, Inc.
Connecticut, United States
Patent: 78
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 65
AskAt, Inc.
Aichi-ken, Japan
Patent: 65
Pfizer Inc.
New York, United States
Patent: 51
Merck Canada, Inc.
Canada
Patent: 47
Cayman Chemical Co., Inc.
Michigan, United States
Patent: 43
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 41
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 19 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Ionova Life Science Co. Ltd.
Guangdong Sheng, China
Patent: 18
STARTUP
Medibiofarma SL
Spain
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 168 patents applied in the last 5 years. We discover 29 most active companies in this area. The fast-growing TempestTx, Inc., Idorsia Pharmaceuticals Ltd., Ionova Life Science Co. Ltd. take 29.17% of patent filing during this period.
TempestTx, Inc.
California, United States
Patent: 18
Idorsia Pharmaceuticals Ltd.
Switzerland
Patent: 16
STARTUP
Ionova Life Science Co. Ltd.
Guangdong Sheng, China
Patent: 15
Asahi Kasei Pharma Corp.
Tokyo-to, Japan
Patent: 14
Shanghai Yuyao Biotechnology Co., Ltd.
China
Patent: 13
Foshan Ionova Biotherapeutics Co., Ltd.
China
Patent: 12
AskAt, Inc.
Aichi-ken, Japan
Patent: 11
Heptares Therapeutics Ltd.
HERTFORD COUNTY, United Kingdom
Patent: 10
Avista Pharma Solutions, Inc.
North Carolina, United States
Patent: 9
DOMAIN THERAPEUTICS
United States
Patent: 8
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 168 patents in last 5 years, we discover 18 new entrants. TempestTx, Inc., Idorsia Pharmaceuticals Ltd., Asahi Kasei Pharma Corp. are the most active new entrants in this area.
TempestTx, Inc.
California, United States
Patent: 18
Idorsia Pharmaceuticals Ltd.
Switzerland
Patent: 16
Asahi Kasei Pharma Corp.
Tokyo-to, Japan
Patent: 14
Heptares Therapeutics Ltd.
HERTFORD COUNTY, United Kingdom
Patent: 10
Avista Pharma Solutions, Inc.
North Carolina, United States
Patent: 9
DOMAIN THERAPEUTICS
United States
Patent: 8
Wuhan Renfu Innovative Drug Research and Development Center Co., Ltd.
Hubei Sheng, China
Patent: 8
Humanwell Healthcare (Group) Co., Ltd.
Hubei Sheng, China
Patent: 5
Anrun Medicine Technology (Suzhou) Co Ltd
Jiangsu Sheng, China
Patent: 3
Shenzhen Jingtai Technology Co., Ltd.
Guangdong Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 4 universities and scientific research institutions by total patent application. The Hong Kong University of Science & Technology, Louisiana State University, East China Normal University are dominant in this area. They take 70.59% of the total patent filing.
The Hong Kong University of Science & Technology
Hong Kong SAR, China
Patent: 4
Louisiana State University
Louisiana, United States
Patent: 2
East China Normal University
Shanghai Shi, China
Patent: 2
Universidad de Concepción
Chile
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: